Aviceda Therapeutics
PrivateLast Round
Series C
Jan 7, 2025
Total Funding Raised
$211.75M
Company Overview
Aviceda Therapeutics is a clinical-stage biotechnology company that develops next-generation immunomodulators to address chronic, non-resolving inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aviceda Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Aviceda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 7, 2025 | ||||
| VC Round | May 31, 2024 | ||||
| VC Round | May 19, 2023 | ||||
| VC Round | Mar 28, 2022 | ||||
| Seed | Sep 16, 2020 |
Key People
Founding team and executive leadership
Aviceda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C, VC Round |
| Enavate Sciences | Series C, VC Round |
| Aberdeen Group | Series C |
| TCG Crossover | Series C, VC Round |
| Omega Funds | Series C, VC Round |
| Digitalis Ventures | Series C, VC Round |
| OrbiMed | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2025
Dr. Emmett T. Cunningham, Jr. joins the board.
- Jan 8, 2025
AVD-104 is a clinical-stage candidate for geographic atrophy.
Aviceda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aviceda Therapeutics's valuation, stock price, and market status.
